Tofacitinib has been reported to activity in the recovery of alopecia areata (AA) in several reports, mainly from Western countries. We report the case of a young Indian boy with resistant AA who was treated with tofacitinib-based therapy. Improvements in terms of hair regrowth were observed within 6-8 weeks of treatment with oral tofacitinib 2.5 mg BID tablets, and the hair regrowth was nearly complete by 5 months. There were no associated side effects and the treatment with tofacitinib was well-tolerated.
Download full-text PDF |
Source |
|---|---|
| http://www.ncbi.nlm.nih.gov/pmc/articles/PMC9447467 | PMC |
| http://dx.doi.org/10.4103/ijt.ijt_15_22 | DOI Listing |
Publication Analysis
Top Keywords
alopecia areata
8
hair regrowth
8
recovery resistant
4
resistant alopecia
4
areata treated
4
tofacitinib
4
treated tofacitinib
4
tofacitinib 8-year-old
4
8-year-old child's
4
child's case
4
Similar Publications
Want AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!